How HIV Destroys the Immune System: CD4+ T-Cell Depletion

HIV targets CD4+ T-helper cells, the orchestrators of adaptive immunity. Progressive loss leads to acquired immunodeficiency syndrome (AIDS).

Pathogenesis

  1. Entry: gp120 binds CD4 + coreceptor (CCR5/CXCR4) → fusion.
  2. Reverse transcription: Viral RNA → DNA (integrase integrates into host genome).
  3. Replication: Host machinery produces virions → budding → cell death (lysis, apoptosis, immune clearance).
  4. CD4 decline: ~50–100 cells/μL/year untreated.

Consequences of CD4 Loss

  • >500 cells/μL: Near-normal immunity.
  • 200–500: Mild immune dysfunction; risk of shingles, thrush, bacterial pneumonia.
  • <200: AIDS-defining opportunistic infections (OIs): PCP, toxoplasmosis, MAC, CMV, cryptococcal meningitis.
  • Malignancies: Kaposi sarcoma, NHL, cervical/anal cancer (HPV-driven).
  • Neurocognitive: HIV-associated neurocognitive disorder (HAND).

Treatment Changes Everything

ART suppresses viral load to undetectable → CD4 recovery → near-normal lifespan, no transmission (U=U). Early initiation is standard.

HIV & AIDS - Related Articles